Publications

Search our bibliography using the filters on the right-hand side.

Displaying 151 through 200 of 264 publications.

Kaplan JR, Anthony MS, Clarkson TB. The antiatherogenic effects of soy phytoestrogens in relation to early and late lesion development. J Nutr. 2002;132:606S.

Gibbs RB, Nelson D, Anthony MS, Clarkson TB. Effects of long-term hormone replacement and of tibolone on choline acetyltransferase and acetylcholinesterase activities in the brains of ovariectomized, cynomologus monkeys. Neuroscience. 2002;113(4):907-14.

Anthony MS. Soy/isoflavones and risk factors for cardiovascular disease. In: Gilani GS, Anderson JJB, editors. Phytoestrogens and health. Champaign: IL. AOCS Press; 2002. p.268-89.

Anthony MS. Phytoestrogens for postsmenopausal women's health. Ginecologia. 2002;27:35.

Burke GL, Legault C, Anthony MS, Bland DR, Morgan TM, Naughton MJ. Soy protein and isoflavone effects on vasomotor symptoms in peri- and post-menopausal women: the soy estrogen alternative study. J Nutr. 2002;132:600S.

Wagner JD, Anthony MS, Cline JM. Soy phytoestrogens: research on benefits and risks. Clin Obstet Gynecol. 2001 Dec;44(4):843-52.

Anthony MS. Ert/hrt: the new and old conundrums. Presented at the 17th World Congress on Fertility and Sterility; November 25, 2001. Melbourne, Australia.

Anthony MS, Blair RM, Clarkson TB. Neither isoflavones nor the alcohol-extracted fraction added to alcohol-washed soy protein isolate restores the lipoprotein effects of soy protein isolate. Presented at the Fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; November 4, 2001. San Diego, CA.

Clarkson TB, Anthony MS, Wagner JD. A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys. J Clin Endocrinol Metab. 2001 Nov;86(11):5396-404.

Williams JK, Anthony MS, Herrington DM. Interactive effects of soy protein and estradiol on coronary artery reactivity in atherosclerotic, ovariectomized monkeys. Menopause. 2001 Sep;8(5):307-13.

Vitolins MZ, Anthony M, Burke GL. Soy protein isoflavones, lipids and arterial disease. Curr Opin Lipidology. 2001 Aug;12(4):433-7.

Anthony MS. Health effects of soy isoflavonoids. Presented at the 3rd International Conference on Natural Antioxidants and Anticarcinogens in Food Health and Disease; June 6, 2001. Helsinki, Finland.

Pan Y, Anthony MS, Binns M, Clarkson TB. A comparison of oral micronized estradiol with soy phytoestrogen effects on tail skin temperatures of ovariectomized rats. Menopause. 2001 May;8(3):171-4.

Anthony MS. Soy and cardiovascular disease. Presented at the 11th World Congress of Food Science and Technology; April 22, 2001. Seoul, South Korea.

Paramastri YA, Anthony MS, Wilkinson LM, Phifer BM, Cline JM. Dietary soy phytoestrogens inhibit tumor promotion by exogenous but not endogenous estrogens in the rat DMBA model of mammary carcinogenesis. Cancer Res. 2001 Mar;42(Suppl):310.

Mikkola TS, Anthony MS, Clarkson TB, St Clair RW. Cholesterol efflux potential of serum from atherogenic diet-fed cynomolgus monkeys after long-term tibolone treatment or traditional hormone replacement therapy. FASEB J. 2001;15(4):A248.

Carnethon MR, Anthony MS, Cascio WE, Folsom AR, Evans GE, Liao D. Prospective association between hormone replacement therapy and the QT index. Circulation. 2001;104:II-792.

Cline JM, Anthony MS, Register TC, Borgerink H, Clarkson TB. Tibolone does not stimulate the endometrium or breast in cynomolgus monkeys. FASEB J. 2001;15(4):A594.

Clarkson TB, Anthony MS, Morgan TM. Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab. 2001 Jan;86(1):41-7.

Clarkson TB, Anthony MS. Effects of SERMs, tibolone, and soy isoflavones on cardiovascular risk factors and coronary artery atherosclerosis of surgically post-menopausal monkeys. J Menopausal Med. 2001;10(1):19-23.

Shadoan MK, Rankin SE, Anthony MS, Clarkson TB, Wagner JD. Tibolone increases lean mass and bone mineral density in cynomolgus monkeys. FASEB J. 2001;15(4):A595.

Anthony MS. Soy protein and heart disease. In: Descheemaeker K, Debruyne I, editors. Soy and health 2000 clinical evidence-dietetic applications. Belgium. Garant, Leuven/Apeldoorn; 2001. p.11-6.

Anthony MS. Soy/phytoestrogens and women's health. Presented at the NAASO 2000 Symposium: Exploring New Trends in Weight Management: Soy-based Diets and Behavioral Approaches to Dieting; November 1, 2000. Long Beach, CA. Previously presented at the 2000 Institute of Food Technologists Annual Meeting.

Anthony MS. Soy and cardiovascular disease: cholesterol lowering and beyond. Presented at the European Week of Soy, sponsored by Alpro Soya; October 3, 2000. Ghent, Belgium. Previously presented at the 3rd International Symposium on the Role of Soy in Preventing and Treating Chronic Disease.

Anthony MS. Soy/phytoestrogens and postmenopausal women's health. Presented at the European Week of Soy; October 2, 2000. Utrecht, The Netherlands.

Anthony MS. Soy and women's health. Presented at the Soy Protein and Health Research Update; August 30, 2000. Sydney, Australia.

Adams MR, Anthony MS, Manning JM, Golden DL, Parks JS. Low-dose contraceptive estrogen-progestin and coronary artery atherosclerosis of monkeys. Obstet Gynecol. 2000 Aug;96(2):250-5.

Anthony MS. Phytoestrogens and the cardiovascular system. Presented at the 5th European Congress on Menopause; July 1, 2000. Copenhagen, Denmark.

Pan Y, Anthony M, Watson S, Clarkson TB. Soy phytoestrogens improve radial arm maze performance in ovariectomized retired breeder rats and do not attenuate benefits of 17beta-estradiol treatment. Menopause. 2000 Jul;7(4):230-5.

Anthony MS. Soy/phytoestrogens and women's health. Presented at the 2000 Institute of Food Technologists Annual Meeting; June 13, 2000. Dallas, TX.

Anthony MS. Soy phytoestrogens as hormone replacement therapy - How do they compare? Presented at the 6th Annual Medicine in the 21st Century Symposium; May 8, 2000. Newark, NJ.

Pan YL, Anthony MS, Kapps M, Clarkson TB. A comparison of the effect of treatment with oral micronized estradiol or phytoestrogen-containing soy protein isolate on tail skin temperatures of ovariectomized rats. Poster presented at the 2000 American Society for Nutritional Sciences Conference; March 2000. [abstract] J Nutr. 2000 Mar; 130(3):706S. doi: 10.1093/jn/130.3.680S

Anthony MS. Soy and cardiovascular disease: cholesterol lowering and beyond. J Nutr. 2000 Mar;130(3):662S-3S.

Cline JM, Anthony MS, Mathes S, Clarkson TB. Effects of dietary soy on the uterus and breast of macaques. J Nutr. 2000;130:669S.

Pan YL, Anthony MS, Clarkson TB. Soy, estradiol, and cognitive function: effects on biomarkers and learning/memory performance of estrogen-deficient rats. J Nutr. 2000;130:677S.

Anthony MS, Clarkson TB, Evans GW. Estrogen-only versus estrogen + progestin replacement therapy: effects on coronary artery atherosclerosis extent and carotid artery intima-media thickness. Presented at the 40th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, American Heart Association; March 1, 2000. San Diego, CA. [abstract] Circulation. 2000; 101(6):714.

Anthony MS. Soy and cardiovascular disease and other potential health effects. Presented at the Iowa Soybean Promotion Board; December 8, 1999. New York, NY.

Anthony MS. Soy: a potential postmenopausal therapy. Presented at the American Public Health Association 127th Annual Meeting and Exposition; November 1999. Chicago, IL.

Anthony MS. Soy and cardiovascular disease: cholesterol lowering and beyond. Presented at the 3rd International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; October 1999. Washington, DC.

Anthony MS. Soy and cardiovascular disease: potential health benefits. Presented at the 6th National Scientific Sessions of the Consortium for Southeastern Hypertension Control; October 1999. San Juan, Puerto Rico.

Anthony MS. The usefulness of clinical trials: examples from soy and isoflavone research. Presented at the Developing breakthroughs in science and technology. Sponsored by Banner Pharmacaps; September 1999. Winston-Salem, NC.

Anthony MS. Soy and CHD. Presented at the World Soybean Research Conference VI; August 1999. Chicago, IL.

Anderson JJB, Anthony M, Messina M, Garner SC. Effects of phyto-oestrogens on tissues. Nutr Res Rev. 1999 Jun;12(01):75-116.

Pan Y, Anthony M, Clarkson TB. Effect of estradiol and soy phytoestrogens on choline acetyl transferase and nerve growth factor mrnas in the frontal cortex and hippocampus of female rats. Proc Soc Exp Biol Med. 1999 Jun;221(2):118-25.

Anderson JJB, Anthony MS, Cline JM, Washburn SA, Garner SC. Health potential of soy isoflavones for menopausal women. Public Health Nutr. 1999 Apr;2(4):489-504.

Pan Y, Anthony M, Clarkson TB. Evidence for up-regulation of brain-derived neurotrophic factor mRNA by soy phytoestrogens in the frontal cortex of retired breeder female rats. Neurosci Lett. 1999 Feb;261(1&2):17-20.

Stavisky RC, Ayers MR, Anthony MS, Hopkins WD, Andrews M, Kaplan JR. Assessment of cognitive performance in reproductively intact and ovariectomized monkeys. Am J Primatol. 1999;49(1):103.

Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause. 1999;6(1):7-13.

Clarkson TB, Anthony MS, Cline JM. Clinical efficacy of phytoestrogens - pharmacology/biology. In: Lobo RA, editors. Treatment of the postmenopausal woman. Philadelphia. Lippincott Williams & Wilkins; 1999. p.577-86.